FOXM1 and breast carcinoma: Further investigation showed that only P5 (the sequence 709-728aa of FOXM1) (Supplemental Fig. 2A) significantly inhibited MDA-MB-231 breast cancer cells in a dose-dependent manner (Fig. 2B), providing a reason to focus on this peptide for further studies.